Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00073892
Status:
COMPLETED
Last Update Posted:
2022-06-27
First Post:
2003-12-10
Brief Title:
PI-88 in Treating Patients With an Advanced Malignancy Cancer or Stage IV Melanoma
Sponsor:
Cellxpert Biotechnology Corp
Organization:
Cellxpert Biotechnology Corp
Organization Data
Organization:
Cellxpert Biotechnology Corp
Class:
INDUSTRY
Study ID:
PROGEN-PR88201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cellxpert Biotechnology Corp
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Medigen Biotechnology Corporation | INDUSTRY |